A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)

Merck Sharp & Dohme LLC95 enrolled

Overview

This is a safety study evaluating the subjects who participated in previous Organon trials of the drug Org 24448. Patients will undergo a Screening visit, 1 or 2 Evaluation visits, and a possible Follow-Up period. During the visits, study tests, including echocardiograms, will be performed to summarize cardiac functioning.

All subjects who participated in previous Org 24448 trials and who do not meet any of the exclusion criteria are eligible.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Psychosis

Interventions

SCH 900460DRUG

Subjects who participated in previous trials of Org 24448 (SCH 900460)

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Subjects must: * be verified by the investigator to have participated in a previous Organon sponsored Org 24448 trial. * sign an affirmative informed consent before evaluations are conducted; Exclusion Criteria: Subjects must not have: * a concurrent acute condition that could interfere with the conduct or interpretation of the evaluations (e.g. acute psychosis; respiratory illness; current experimental medications). If possible, evaluation of such subjects is deferred until resolution of such conditions.

Outcomes

Primary Outcomes

Overall cardiac function by cardiologist evaluation including echocardiogram.

Time frame: During the Evaluation Period (Visit 1 or 2 and 3 if applicable).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.